Goodall RL, Meredith SK, Nunn AJ, Bayissa A, et al. Evaluation of two short standardised regimens for the treatment of rifampicin-resistant tuberculosis (STREAM stage 2): an open-label, multicentre, randomised, non-inferiority trial. Lancet 2022 Nov 7. pii: S0140-6736(22)02078.
PMID: 36368336